Middle East, North Africa, Afghanistan & Pakistan vs Poland: Treatment for hypertension, female

Middle East, North Africa, Afghanistan & Pakistan
48.4%
in 2019
Poland
67.6%
in 2019
Middle East, North Africa, Afghanistan & Pakistan rank
16th
Poland rank
19th

Treatment for hypertension, female over time

  • Middle East, North Africa, Afghanistan & Pakistan
  • Poland
0204060199020042019

How they compare

Poland currently reports 67.6% against 48.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 19.2%.

That makes Poland's figure about 1.4 times Middle East, North Africa, Afghanistan & Pakistan's.

Across all 30 years both countries report, Poland has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan ranks 16th and Poland ranks 19th of 43 groups.

Poland has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan Poland Difference Ahead
1990s 30.0% 39.0% 9.0% Poland
2000s 40.2% 54.4% 14.2% Poland
2010s 47.7% 65.0% 17.3% Poland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, female, Middle East, North Africa, Afghanistan & Pakistan or Poland?
Poland, at 67.6% against 48.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2019.
What is the difference in treatment for hypertension, female between Middle East, North Africa, Afghanistan & Pakistan and Poland?
19.2%, with Poland ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Poland?
30 years are reported by both, from 1990 to 2019.
How do Middle East, North Africa, Afghanistan & Pakistan and Poland rank globally for treatment for hypertension, female?
Middle East, North Africa, Afghanistan & Pakistan ranks 16th and Poland ranks 19th of 43 groups.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan vs Poland: Treatment for hypertension, female. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 18 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-female-percent-of-female-adults-ages-30-79-with-hypertension/middle-east-north-africa-afghanistan-and-pakistan/poland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-female-percent-of-female-adults-ages-30-79-with-hypertension/middle-east-north-africa-afghanistan-and-pakistan/poland/">Middle East, North Africa, Afghanistan & Pakistan vs Poland: Treatment for hypertension, female</a> — Statizoid

About this data

Indicator
Treatment for hypertension, female (% of female adults ages 30-79 with hypertension)
Unit
% of female adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.